Qalsody is one step closer to being covered by public Canadian healthcare systems when used to treat adults with ALS with ...

The FDA has cleared Neurosense to begin its pivotal Phase 3 clinical trial of PrimeC for the treatment of amyotrophic lateral ...

In addition to ALS, pridopidine is in late-stage clinical development for HD, with Prilenia and Ferrer planning to initiate a confirmatory study in HD designed to confirm pridopidine's effects and ...

The man behind the Moose Jaw health centre that has claimed “a 100 per cent success rate in stopping the progression and in ...

New hope could be on the horizon for ALS patients in the form of a "breakthrough" drug, researchers say. Neuvivo, a California biopharmaceutical company that develops therapies for neurodegenerative ...

Please provide your email address to receive an email when new articles are posted on . The treatment group logged longer times to four disease-progression milestones compared with controls. At 2 ...

IV edaravone-treated patient had longer disease progression milestone-free time for all 6 milestones compared with control. Treatment with intravenous (IV) edaravone was associated with fewer reported ...

When I was interviewed on the Today show in 2023, I told Savannah Guthrie, "Levity is my superpower." It's true, although before I was diagnosed, that wasn't always such a good thing. At work, I was ...

Amyotrophic lateral sclerosis (ALS) affects the nerve cells in the brain and spinal cord that control muscle movement. Different types of ALS cause symptoms to begin in a certain part of the body and ...

There is currently no known cure for ALS, but some treatments, including FDA-approved medications such as Rilutek -- whose ...

Over the course of the last three years, Brooke Eby has documented the progression of her condition for an audience of over 300,000 social media followers Courtesy of Brooke Eby Brooke Eby was ...